Capital Fund Management S.A. Acadia Pharmaceuticals Inc Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 784,029 shares of ACAD stock, worth $12.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

784,029

Previous 916,609 14.46%

Holding current value

$12.8 Million

Previous $14.9 Million 18.99%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $2.01 Million - $2.54 Million	-132,580 Reduced 14.46%	784,029 $12.1 Million
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $3.23 Million - $4.07 Million	221,062 Added 31.78%	916,609 $14.9 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $8.04 Million - $13.9 Million	451,735 Added 185.28%	695,547 $12.9 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $1.42 Million - $2.16 Million	68,120 Added 38.77%	243,812 $7.63 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $1.16 Million - $1.87 Million	-55,769 Reduced 24.09%	175,692 $3.66 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $1.26 Million - $1.81 Million	70,616 Added 43.9%	231,461 $5.54 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $1.3 Million - $1.67 Million	-79,626 Reduced 33.11%	160,845 $3.03 Million
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $321,701 - $422,062	-22,655 Reduced 8.61%	240,471 $3.83 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $853,288 - $1.1 Million	60,474 Added 29.84%	263,126 $4.3 Billion
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $1.59 Million - $3.34 Million	122,533 Added 152.94%	202,652 $0
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $567,013 - $744,645	27,078 Added 51.05%	80,119 $0
Q4 2021 Feb 10, 2022	SELL	$16.79 - $27.09 $139,440 - $224,982	-8,305 Reduced 13.54%	53,041 $0
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $411,195 - $645,456	26,058 Added 73.84%	61,346 $0
Q2 2021 Aug 12, 2021	BUY	$19.4 - $27.42 $684,587 - $967,596	35,288 New	35,288 $0
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $556,092 - $769,504	-13,550 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $126,632 - $198,189	-3,477 Reduced 20.42%	13,550 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $668,480 - $897,833	17,027 New	17,027 $0
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $268,803 - $398,066	-8,493 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $15,823 - $22,461	-437 Reduced 4.89%	8,493 $363,000
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $198,424 - $393,009	8,930 New	8,930 $321,000

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Acadia Pharmaceuticals Inc Transaction History